Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, ora...
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
WHYY released its performance for the first three quarters, with a net profit attributable to the parent company of 63.995 million yuan, an increase of 179.34%
WHYY: Directors plan to reduce holdings by 0.44%
11 companies disclosed their semi-annual reports for 2025, only WHYY saw an increase in holdings from QFII on a quarter-on-quarter basis
The first batch of semi-annual reports from the Shenzhen Stock Exchange has been released, with four companies showing "double growth" in performance